The EPS projection of Illumina, Inc. (NASDAQ:ILMN) for quarter ended 2016-09-30 is $0.9. A week before, the EPS forecast was $0.9 against target of $0.9, a month earlier. This estimate stood at $0.9 60 days earlier versus forecast of $0.9 90 days earlier, confirming a deviation of 0%.
Illumina, Inc. (NASDAQ:ILMN) reported that 18 days ago, the positive EPS revisions were 1 and negative revisions at 8.
In last week, the per-share earnings was lowered 0 times and 0 times positively. In last 120, 60, 30 and 90 days the positive revisions were 1, 2, 0 and 1, respectively.
The downgrade of EPS estimates for Illumina, Inc. (NASDAQ:ILMN) in the preceding 120, 60, 30 and 90 days were 9, 8, 0 and 9, in that order.
As per the latest update, for the quarter closed 1, the EPS estimate of Illumina, Inc. (NASDAQ:ILMN) was $0.9. This projection was computed after accounting 13 calls. As reported on 2016-05-03 the EPS was $0.71. The change was $-0.03, demonstrating a percentage deviation of -4.05%. The projections confirmed a standard deviation of 0.04.
Quarterly Sales Estimates
For the fiscal 2017, the yearly sales target for Illumina, Inc. (NASDAQ:ILMN) stands at $772.555 and the median estimate at $772.555. Almost 2 analysts announced their estimates.
The highest estimate is $809.111 while the lowest target is $736 showing standard deviation of 51.697%.
As many as 2 analysts released sales estimates reised in upside while 2 reduced sales estimates, demonstrating a deviation of 0%.
In last month, 2 revised sales number projection on upside while 2 lowered the sales target, demonstrating a deviation of 0%.
A quarter ago, 2 hiked sales estimations and 2 reduced sales forecast. Illumina, Inc. (NASDAQ:ILMN) stated that the change in forecast was -3.175%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...